Compare SEAT & BTMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SEAT | BTMD |
|---|---|---|
| Founded | 2001 | 2012 |
| Country | United States | United States |
| Employees | 565 | N/A |
| Industry | Industrial Machinery/Components | Medicinal Chemicals and Botanical Products |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 79.0M | 65.8M |
| IPO Year | N/A | 2021 |
| Metric | SEAT | BTMD |
|---|---|---|
| Price | $7.47 | $2.25 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 8 | 3 |
| Target Price | ★ $18.06 | $2.83 |
| AVG Volume (30 Days) | 65.7K | ★ 204.5K |
| Earning Date | 05-05-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 722.22 |
| EPS | N/A | ★ 0.06 |
| Revenue | N/A | ★ $192,219,000.00 |
| Revenue This Year | N/A | $2.03 |
| Revenue Next Year | $4.60 | $6.58 |
| P/E Ratio | ★ N/A | $37.00 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $5.06 | $1.27 |
| 52 Week High | $35.00 | $4.20 |
| Indicator | SEAT | BTMD |
|---|---|---|
| Relative Strength Index (RSI) | 49.97 | 50.47 |
| Support Level | $7.29 | $1.99 |
| Resistance Level | $7.85 | $2.49 |
| Average True Range (ATR) | 0.61 | 0.18 |
| MACD | 0.07 | -0.02 |
| Stochastic Oscillator | 45.25 | 43.55 |
Vivid Seats Inc is an online ticket marketplace for connecting fans to live events and artists. It is the official ticketing partner of brands in the entertainment industry, providing tickets for sports, concerts, theatres, and comedy events in the United States, Canada, and Japan. It operates in two segments: Marketplace, which generates maximum revenue, and Resale. The Marketplace segment acts as an intermediary between ticket buyers, sellers, and partners, earning revenue from processing ticket sales for live events and facilitating the booking of hotel rooms and packages on websites and mobile applications. The Resale segment acquires tickets to resell on secondary ticket marketplaces, including its own, and offers internal research and development support for Skybox.
Biote Corp operates a growth practice-building business within the hormone optimization space. It provides the necessary components to enable Biote-certified practitioners to establish, build, and successfully implement a program designed to optimize hormone levels using personalized solutions for their patient populations. The company provides support to medical practitioners through training, practice development, and operational services to establish and manage hormone therapy centers. Its activities include educating practitioners on identifying and treating hormone-related conditions. The company generates revenues by charging the Biote-partnered clinics fees associated with the Biote Method and from the sale of Biote-branded dietary supplements.